For the Inventor, By the Inventor

Enter assignee name

Nanobiotix

USPTO Granted Patents = 16

CIPO Patents = 2

EPO Patents = 13

Trademarks = 15

Forward Citations = 47

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Laurent Levy (16 out of 26 patents)

Agnes Pottier (9 out of 13 patents)

Matthieu Germain (7 out of 12 patents)

4. Marie-Edith Meyre (6 out of 16 patents)

5. Agnès Pottier (3 out of 11 patents)

6. Laurence Poul (3 out of 5 patents)

7. Julie Marill (2 out of 2 patents)

8. Elsa Borghi (2 out of 3 patents)

9. Agnés Pottier (2 out of 2 patents)

10. Laurence Maggiorella (2 out of 2 patents)

11. Paras Nath Prasad (2 out of 15 patents)

12. Earl Jim Bergey (2 out of 6 patents)

13. Abdel Kader Boussaha (2 out of 2 patents)

14. Jérémy Balencie (2 out of 2 patents)

15. Audrey Darmon (1 out of 3 patents)

16 patents: Sort by Forward Citations

1. 11229705 - Coated nanoparticles for use for modulating electrical polarization of neurons (2022-01-25),

2. 11096962 - Nanoparticles for use as a therapeutic vaccine (2021-08-24),

3. 11020480 - Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer (2021-06-01),

4. 10945965 - Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof (2021-03-16),

5. 10588987 - Compositions and methods for use in medical diagnosis (2020-03-17),

6. 10413509 - Pharmaceutical composition, preparation and uses thereof (2019-09-17),

7. 10391174 - Metallic nanoparticles, preparation and uses thereof (2019-08-27),

8. 10391058 - Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof (2019-08-27),

9. 10265406 - Pharmaceutical composition comprising nanoparticles, preparation and uses thereof (2019-04-23),

10. 10098952 - Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer (2018-10-16),

11. 10064962 - Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles (2018-09-04),

12. 9956175 - Nanoparticles delivery systems, preparation and uses thereof (2018-05-01),

13. 9700621 - Metallic nanoparticles, preparation and uses thereof (2017-07-11),

14. 9433800 - Activatable particles, preparation and uses (2016-09-06),

15. 9162079 - Activatable particles, preparations and uses (2015-10-20),

NANOBIOTIX is a French clinical-stage nanomedicine company pioneering nanomedicine approaches to enhance treatment outcomes for patients. They focus on developing nanoXray, a proprietary technology platform that targets and destroys cancer cells while preserving healthy tissue. The company's innovative therapies aim to provide a more efficient and personalized approach to cancer treatment.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#251 in Paris

#1,185 in France

#36,684 in the World

Nanobiotix

Forward Citations = 47

25 inventors:

Laurent Levy (16 out of 26 patents)

Agnes Pottier (9 out of 13 patents)

Matthieu Germain (7 out of 12 patents)

4. Marie-Edith Meyre (6 out of 16 patents)

5. Agnès Pottier (3 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…